Dynamics of Parasite Clearance in Cutaneous Leishmaniasis Patients Treated with Miltefosine

Randomized Controlled Clinical Trial to Access Efficacy and Safety of Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

(2011) Anette Chrusciak-Talhari et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Visceral leishmaniasis: elimination with existing interventions

(2011) Greg Matlashewski et al.   LANCET INFECTIOUS DISEASES

Mucosal Leishmania infantum infection

(2011) Joachim Richter et al.   PARASITOLOGY RESEARCH

First Cases of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) naiffi Infection in Surinam

(2010) Pieter-Paul A. M. van Thiel et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Miltefosine Treatment ofLeishmania majorInfection: An Observational Study Involving Dutch Military Personnel Returning from Northern Afghanistan

(2009) P. P. A. M. van Thiel et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients

(2008) T. P. C. Dorlo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography–tandem mass spectrometry

(2008) Thomas P.C. Dorlo et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES